Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2903)
All Articles published online
|
Jul 15, 2003 (publication date) through Dec 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jaboli MF, Fabbri C, Liva S, Azzaroli F, Nigro G, Giovanelli S, Ferrara F, Miracolo A, Marchetto S, Montagnani M, Colecchia A, Festi D, Reggiani LB, Roda E, Mazzella G. Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe-positive chronic hepatitis B: Results of an open, controlled trial. World J Gastroenterol 2003; 9(7): 1491-1495 [PMID: 12854148 DOI: 10.3748/wjg.v9.i7.1491] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i7/1491.htm |
| Number | Citing Articles |
| 1 |
G. L.‐H. Wong, V. W.‐S. Wong, H. L.‐Y. Chan. Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis B. Journal of Viral Hepatitis 2014; 21(12): 825 doi: 10.1111/jvh.12341
|
| 2 |
Jun Liu, Ying Guo, Cai-Fang Xue, Ying-Hui Li, Yu-Xiao Huang, Jin Ding, Wei-Dong Gong, Ya Zhao. Effect of vector-expressed siRNA on HBV replication in hepatoblastoma cells. World Journal of Gastroenterology 2004; 10(13): 1898-1901 doi: 10.3748/wjg.v10.i13.1898
|
| 3 |
Ying Chen, Johnny Sze, Ming-Liang He. HBV cccDNA in patients’ sera as an indicator for HBV reactivation and an early signal of liver damage. World Journal of Gastroenterology 2004; 10(1): 82-85 doi: 10.3748/wjg.v10.i1.82
|
| 4 |
Tirasak Pasharawipas. Inducible viral receptor, A possible concept to induce viral protection in primitive immune animals. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-326
|
| 5 |
NIKOLAOS L NIKOLAIDIS, OLGA I GIOULEME, KONSTANTINOS A TZIOMALOS, ADAMOS S SAVERIADIS, NIKOLAOS GRAMMATIKOS, PANAGIOTIS DOUKELIS, ANASTASIOS D VOUTSAS, THEMISTOKLIS VASSILIADIS, KALLIOPI PATSIAOURA, ELENI ORFANOU‐KOUMERKERIDOU, AIKATERINI BALASKA, NIKOLAOS P EUGENIDIS. Interferon/long‐term lamivudine combination therapy in anti‐HBe positive chronic hepatitis B patients. Journal of Gastroenterology and Hepatology 2005; 20(11): 1721 doi: 10.1111/j.1440-1746.2005.04029.x
|
| 6 |
Jules L Dienstag, Lee-Jen Wei, Dong Xu, Bruce Kreter. Cross-Study Analysis of the Relative Efficacies of Oral Antiviral Therapies for Chronic Hepatitis B Infection in Nucleoside-Naive Patients. Clinical Drug Investigation 2007; 27(1): 35 doi: 10.2165/00044011-200727010-00003
|
| 7 |
Duckhyang Shin, Soo In Kim, Meehyein Kim, Mahnhoon Park. Efficient inhibition of hepatitis B virus replication by small interfering RNAs targeted to the viral X gene in mice. Virus Research 2006; 119(2): 146 doi: 10.1016/j.virusres.2005.12.012
|
| 8 |
Michalis Economou, Spilios Manolakopoulos, Thomas A Trikalinos, Spyros Filis, Sotiris Bethanis, Dimitrios Tzourmakliotis, Alec Avgerinos, Sotiris Raptis, Epameinondas V Tsianos. Interferon-α plus lamivudine <italic>vs</italic> lamivudine reduces breakthroughs, but does not affect sustained response in HBeAg negative chronic hepatitis B. World Journal of Gastroenterology 2005; 11(37): 5882-5887 doi: 10.3748/wjg.v11.i37.5882
|
| 9 |
Zheng-Wen Liu, Qun-Ying Han, Ni Zhang, Wen Kang. Sequential changes of serum ferritin levels and their clinical significance in lamivudine-treated patients with chronic viral hepatitis B. World Journal of Gastroenterology 2004; 10(7): 972-976 doi: 10.3748/wjg.v10.i7.972
|
| 10 |
Emma C Thomson, Janice Main. Advances in hepatitis B and C. Current Opinion in Infectious Diseases 2004; 17(5): 449 doi: 10.1097/00001432-200410000-00010
|
| 11 |
E. K. MANESIS, G. V. PAPATHEODORIDIS, S. J. HADZIYANNIS. A partially overlapping treatment course with lamivudine and interferon in hepatitis B e antigen‐negative chronic hepatitis B. Alimentary Pharmacology & Therapeutics 2006; 23(1): 99 doi: 10.1111/j.1365-2036.2006.02731.x
|
| 12 |
Jun Liu, Ying-Hui Li, Jin Ding, Wei-Dong Gong, Cai-Fang Xue, Ya Zhao, Yu-Xiao Huang. Quantifying anti-HBV effect of targeted ribonuclease by real-time fluorescent PCR. World Journal of Gastroenterology 2004; 10(19): 2883-2885 doi: 10.3748/wjg.v10.i19.2883
|
| 13 |
Chee-kin Hui, Hai-ying Zhang, George K.K. Lau. Management of chronic hepatitis B in treatment-experienced patients. Gastroenterology Clinics of North America 2004; 33(3): 601 doi: 10.1016/j.gtc.2004.04.009
|
| 14 |
Dong Xu, De-Ying Tian, Zhen-Gang Zhang, Hong-Yun Chen, Pei-Hui Song. Effect of SEN virus coinfection on outcome of lamivudine therapy in patients with hepatitis B. World Journal of Gastroenterology 2004; 10(7): 968-971 doi: 10.3748/wjg.v10.i7.968
|
| 15 |
Konstantinos Tziomalos. Combination treatment in HBeAg-negative chronic hepatitis B. World Journal of Hepatology 2009; 1(1): 43-47 doi: 10.4254/wjh.v1.i1.43
|